Supplementary Figure 5: GABAB-receptor- and A1-receptor-mediated presynaptic inhibition of excitatory synaptic transmission in PV interneurons are not affected by NL3 deletion | Nature Neuroscience

Supplementary Figure 5: GABAB-receptor- and A1-receptor-mediated presynaptic inhibition of excitatory synaptic transmission in PV interneurons are not affected by NL3 deletion

From: Modulation of excitation on parvalbumin interneurons by neuroligin-3 regulates the hippocampal network

Supplementary Figure 5

a-d, The depression of excitatory synaptic transmission in PV interneurons by the GABAB receptor agonist baclofen (10 μM) is not affected by NL3 deletion. Time course of normalized AMPAR EPSCs during application of baclofen (a) and sample EPSCs in response to paired pulse stimulation before and after baclofen application (b) in PV-Cre (before-black, after-blue) and NL3fl/PV-Cre (before-orange, after-green) neurons. Summary plot of normalized EPSC changes due to baclofen (c) and normalized PPR changes (d) in individual cells (PV-Cre, 0.4 ± 0.1, 1.3 ± 0.1, n = 4; NL3fl/PV-Cre, 0.4 ± 0.1, 1.3 ± 0.04, n = 6) e-h, Same as a-d but for the application of A1-R agonist N6-CPA (1 μM). Representative EPSCs (f) before and after N6-CPA for PV-Cre (before-black, after-blue) and NL3fl/PV-Cre (before-orange, after-green). Individual normalized EPSC (g) and PPR (h) changes caused after N6-CPA (PV-Cre, 0.3 ± 0.05, 1.1 ± 0.1, n = 6; NL3fl/PV-Cre, 0.3 ± 0.03, 1.0 ± 0.02, n = 4).

Back to article page